114 related articles for article (PubMed ID: 8200896)
1. Melanoma of the foot.
Barnes BC; Seigler HF; Saxby TS; Kocher MS; Harrelson JM
J Bone Joint Surg Am; 1994 Jun; 76(6):892-8. PubMed ID: 8200896
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma of the foot and ankle.
Fortin PT; Freiberg AA; Rees R; Sondak VK; Johnson TM
J Bone Joint Surg Am; 1995 Sep; 77(9):1396-403. PubMed ID: 7673291
[TBL] [Abstract][Full Text] [Related]
3. Melanoma of the Foot Is Associated With Advanced Disease and Poorer Survival.
Adams BE; Peng PD; Williams ML
J Foot Ankle Surg; 2018; 57(1):52-55. PubMed ID: 29037928
[TBL] [Abstract][Full Text] [Related]
4. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
Finley JW; Gibbs JF; Rodriguez LM; Letourneau R; Driscoll D; Kraybill W
Am Surg; 2000 Jun; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
[TBL] [Abstract][Full Text] [Related]
5. Acral melanoma: a review of 185 patients with identification of prognostic variables.
Slingluff CL; Vollmer R; Seigler HF
J Surg Oncol; 1990 Oct; 45(2):91-8. PubMed ID: 2214797
[TBL] [Abstract][Full Text] [Related]
6. Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome.
Sanlorenzo M; Osella-Abate S; Ribero S; Marenco F; Nardò T; Fierro MT; Novelli M; Cervetti O; Bernengo MG; Quaglino P
Int J Dermatol; 2015 Sep; 54(9):1023-9. PubMed ID: 25660506
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of localized melanoma of the foot: a case-control study.
Talley LI; Soong S; Harrison RA; McCarthy WH; Urist MM; Balch CM
J Clin Epidemiol; 1998 Oct; 51(10):853-7. PubMed ID: 9762878
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with melanoma of the lower extremity decreases with distance from the trunk.
Hsueh EC; Lucci A; Qi K; Morton DL
Cancer; 1999 Jan; 85(2):383-8. PubMed ID: 10023706
[TBL] [Abstract][Full Text] [Related]
9. Survival with regional and distant metastases from cutaneous malignant melanoma.
Roses DF; Karp NS; Oratz R; Dubin N; Harris MN; Speyer J; Boyd A; Golomb FM; Ransohoff J; Dugan M
Surg Gynecol Obstet; 1991 Apr; 172(4):262-8. PubMed ID: 2006449
[TBL] [Abstract][Full Text] [Related]
10. Acral (volar-subungual) melanoma in Auckland, New Zealand.
Shaw JH; Koea JB
Br J Surg; 1988 Jan; 75(1):69-72. PubMed ID: 3337957
[TBL] [Abstract][Full Text] [Related]
11. Juvenile malignant melanoma.
Reintgen DS; Vollmer R; Seigler HF
Surg Gynecol Obstet; 1989 Mar; 168(3):249-53. PubMed ID: 2919354
[TBL] [Abstract][Full Text] [Related]
12. Plantar melanoma: is the prognosis always bad?
Baumert J; Schmidt M; Kunte C; Volkenandt M; Ruzicka T; Berking C; Schmid-Wendtner MH
Dermatol Surg; 2010 Aug; 36(8):1325-7. PubMed ID: 20584045
[No Abstract] [Full Text] [Related]
13. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.
Väisänen A; Kallioinen M; Taskinen PJ; Turpeenniemi-Hujanen T
J Pathol; 1998 Sep; 186(1):51-8. PubMed ID: 9875140
[TBL] [Abstract][Full Text] [Related]
14. Survival of patients with primary pedal melanoma.
Walsh SM; Fisher SG; Sage RA
J Foot Ankle Surg; 2003; 42(4):193-8. PubMed ID: 12907929
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
16. Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics.
Luen S; Wong SW; Mar V; Kelly JW; McLean C; McArthur GA; Haydon A
Am J Clin Oncol; 2018 Jan; 41(1):90-94. PubMed ID: 26325493
[TBL] [Abstract][Full Text] [Related]
17. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
18. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
19. Management of cutaneous melanoma in the United States.
Balch CM; Karakousis C; Mettlin C; Natarajan N; Donegan WL; Smart CR; Murphy GP
Surg Gynecol Obstet; 1984 Apr; 158(4):311-8. PubMed ID: 6710291
[TBL] [Abstract][Full Text] [Related]
20. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
